Anchorage Capital Group, L.L.C.

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Anchorage Capital Group, L.L.C. reported 5 stock positions worth $316.7 million. Its top holding was Frontier Communications Pare (FYBR) at 42.3% of the portfolio, followed by Sentinelone Class A (S, 32.8%) and Roivant Sciences (ROIV, 16.1%). Compared with Q1 2024, it sold out of 1. The biggest sale was an exit from Consolidated Comm.

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001300714
Portfolio Value
$316.7M (Q2 2024)
SEC Filing
0000905148-24-002242 ↗ filed Aug 14, 2024

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $377.5M Q1 2024 Q2 2024: $316.7M $316.7M Q2 2024 Q3 2024: $374.8M Q3 2024 Q4 2024: $272.5M Q4 2024 Q1 2025: $239.9M Q1 2025 Q2 2025: $258.7M Q2 2025 Q3 2025: $117.4M Q3 2025 Q4 2025: $88.6M Q4 2025 Q1 2026: $436.3M Q1 2026 Q2 2026: $450.5M Q2 2026

Holdings 5 stocks · $316.7M
FYBR Frontier Communications Pare 42.35% 5,123,545 $134.1M No change
S Sentinelone Inc. Class A 32.81% 4,937,053 $103.9M No change
ROIV Roivant Sciences Ltd. 16.13% 4,832,642 $51.1M No change
DNA Ginkgo Bioworks Holdings Inc. 7.37% 69,854,593 $23.4M No change
AMBP Ardagh Metal Packaging SA 1.34% 1,250,000 $4.3M No change
Other holdings (3): bonds, preferreds, convertibles and warrants · $7.2M (not counted above)
SecurityClassShares / PrincipalValueChange
THE REALREAL INC (REAL 1 03/01/28) NOTE 1.000% 3/0 · principal 15,097,000$7.2MNo change
AMPWF Ardagh Metal Packaging -CW26 *W EXP 08/04/202 1,245,385$43KNo change
DNABW Ginkgo Bioworks -CW27 *W EXP 09/16/202 50,000$1KNo change

Total filed on the 13F, all lines: $324.0M.

Portfolio Sells Q1 2024 → Q2 2024
CONSOLIDATED COMM HLDGS INC Sold out 0.00% −0.17

Portfolio Buys Q1 2024 → Q2 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$450.5MEQPT, S, DNA
Q1 2026 3$436.3MEQPT, S, DNA
Q4 2025 2$88.6MS, DNA
Q3 2025 3$117.4MS, DNA, AMBP
Q2 2025 5$258.7MS, FYBR, ROIV, DNA, AMBP
Q1 2025 5$239.9MS, FYBR, ROIV, DNA, AMBP
Q4 2024 5$272.5MS, FYBR, ROIV, DNA, AMBP
Q3 2024 5$374.8MFYBR, S, ROIV, DNA, AMBP
Q2 2024 5$316.7MFYBR, S, ROIV, DNA, AMBP
Q1 2024 6$377.5MFYBR, S, DNA, ROIV, AMBP